Introducing two new tests delivering breakthrough accuracy in COVID-19 detection.
In the face of the global COVID-19 pandemic, PathogenDx is contributing two new testing solutions—leveraging one-of-a-kind DNA microarray technology.
DetectX-Rv is a multiplexed viral diagnostic assay for the detection of SARS-CoV-2, with high specificity and maximum sensitivity.
EnviroX-Rv is an airborne and surface sampling environmental monitoring test.
Both tests deliver multiple inherent benefits beyond any currently approved FDA-approved tests. Find out how the microarray matters for laboratories and companies like your own.
Microarray Testing Advantages
Capability: Combines RT-PCR with DNA microarray, for identification of SARS-CoV-2 (N1, N2, and N3 genes and RNase P gene). Detection down to 50 genome copies per reaction for best-in-class sensitivity.
Specificity: Specific qualitative detection of SARS-CoV-2.
Throughput: Our microarray allows for 96 tests per kit, with additional throughput up to 384 samples using continuous processing and automation.
Applications: Works with all approved nasopharyngeal swabs, nasal aspirate/fluid, and viral DNA/RNA purification kits.
Ultrarapid: Results in 6-8 hours from receipt of the sample.
|
|
- Maximum Sensitivity
- Unique Specificity
- Triplicate Testing per Sample
- Best-in-Class Signal-to-Background detection
- Positive + Negative Controls
- Results in 6 hours after RNA extraction.
- Airborne+Surface Detection
- High Collection Analysis
- Maximum Sensitivity
- Unique Specificity
- Results in 6 hours after RNA extraction.